[1]
“Preoperative treatment with 5α-reductase inhibitors and the risk of hemorrhagic events in patients undergoing transurethral resection of the prostate – A population-based cohort study”, Clinics, vol. 73, p. e264, Jan. 2018, doi: 10.6061/clinics/2018/e264.